Integration of excipient portfolios supported by US Drug Master Files (Type IV) to streamline regulatory submissions and variations.
Alignment with highly regulated pharmaceutical markets including the United States, European Union, Canada, and Australia.
End-to-end documentation continuity encompassing traceability, stability data, and regulatory reference support.
Materials originating from GMP and GLP audited production environments, aligned with sterile product expectations.
CTH Urbana Pvt Ltd functions as an integrated solutions partner, enabling technical interpretation and regulatory alignment between qualified supply sources and regulated pharmaceutical programs.
CTH Urbana Pvt Ltd functions as an integrated solutions partner, enabling technical interpretation and regulatory alignment between qualified Excipients sources and regulated pharmaceutical programs.
